EWTX
HealthcareEdgewise Therapeutics, Inc.
$23.57
$-0.18 (-0.76%)
Jan 5, 2026
Price History (1Y)
Analysis
Edgewise Therapeutics, Inc. is a biotechnology company in the healthcare sector with a market capitalization of $2.50B and 136 employees. The company's financial health is marked by significant losses, with a net income (TTM) of -$157,240,992 and an EBITDA of -$178,831,008. The gross margin, operating margin, and profit margin are all at 0.0%. Returns on equity and assets are negative, standing at -30.0% and -20.7%, respectively. The company's debt to equity ratio is 0.75, while cash on hand totals $563.34M. The valuation of Edgewise Therapeutics, Inc. is characterized by a forward P/E ratio of -11.91 and an EV/EBITDA of -10.93. The price to book ratio is 4.46.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Edgewise Therapeutics, Inc.
Edgewise Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of muscle disorders. Its lead product candidate, EDG-5506, an orally administered small molecule that is in Phase II clinical trials, designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy. The company develops EDG-7500, a small molecule for the treatment of hypertrophic cardiomyopathy and other severe cardiac disorders that is in Phase I clinical trials. In addition, it develops a pipeline of precision medicine product candidates that target key muscle proteins and modulators to address genetically defined muscle disorders. The company was incorporated in 2017 and is headquartered in Boulder, Colorado.
Visit website →Key Statistics
- Market Cap
- $2.50B
- P/E Ratio
- N/A
- 52-Week High
- $30.48
- 52-Week Low
- $10.60
- Avg Volume
- 1.37M
- Beta
- 0.27
Company Info
- Industry
- Biotechnology
- Exchange
- NMS
- Country
- United States
- Employees
- 136